Ongentys press release welcomes the launch of a new drug (to Ireland), Ongentys. had many consultations with the pharmaceutical company Bial and also advocated to have this drug in Ireland. This was sought to be in line with the treatment options available to people living with Parkinson’s in Europe.   Parkinson’s is a complex disease to treat, therefore we need as many options as possible.  See Bial’s information sheet for details about this medication.